Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients

NCT00483743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Copd Bronchitis

Interventions

DRUG: TPI 1020
DRUG: Budesonide
DRUG: Placebo

Sponsor

Syntara